NITI Aayog says no proposal for MTNLS’s disinvestment or closure

Amitabh Kant has assured that there won't be any unprecedented move against MTNL or its employees

GN Bureau | October 28, 2016


#PMO   #Amitabh Kant   #MTNL   #Niti Aayog   #DoT  


 The government has ruled out the disinvestment plan for state-run Mahanagar Telephone Nigam Limited (MTNL), for the time being. After massive protests by employees' union of MTNL, NITI Aayog has cleared the air, saying that as of now there is no proposal of strategic sale or closure of the government-run telecom firm, according to a news report published in The Pioneer.

After media reports of the MTNL's strategic sale, followed by the government's move for the same in a select few loss-making PSU units, employees of MTNL panicked. They appealed to the prime minister's office (PMO), NITI Aayog, telecom ministry and department of telecommunication (DoT) for its revival.
 
Niti Aayog Chief Executive Officer (CEO) Amitabh Kant in a letter has assured that there won't be any such unprecedented move against MTNL or its employees, but he had never mentioned any way out or revival mechanism for a long-term sustainability plan of the continuous loss-making firm. 
 
However, according to the news report there is still no clarity on the fate of MTNL as the proposal of disinvestment or strategic sale of MTNL is still pending in the PMO for consideration. 
 
The PSU telecom firm, which offers services in Delhi and Mumbai, has been without a full-time CMD since May 30, 2014, when AK Garg retired from the post. However, PK Purwar, director (finance) of MTNL was given additional charge for the post from June 2014. From June 2015 to June 2016, NK Yadav, who is member (services), held the charge. Purwar was again given the additional charge in June 2016, after completion of Yadav's tenure. 
 
For this key post, the government had sought suitable candidates who were required to submit their applications before September 8, 2016. Purwar's name had been recommended for the MTNL's top post by the PESB in November 2013, but the government did not go ahead with the recommendation.
 

Comments

 

Other News

Retail inflation crosses 6% mark

Retail inflation based on Consumer Price Index for October has reached 6.09%, whereas year-on-year food inflation, based on Consumer Food Price Index, for October is 8.94%, an official release said on Thursday.   Year-on-year inflation rate based on All India Consumer Price I

Cabinet approves museum at North-South Block complex

The Cabinet Committee on Economic Affairs, chaired by prime minister Narendra Modi, on Wednesday has approved the development of the Yuge Yugeen Bharat Museum (YYBM) at the North and South Block Complex, New Delhi, at an estimated total project cost of ₹3,230 crore, as appraised by the Public Investmen

Cabinet approves extension of Noida metro corridor

The Union Cabinet, chaired by prime minister Narendra Modi, has approved the extension of Aqua Line Metro Rail Corridor from Noida Sector-51 to Greater Noida Sector-04 of Noida Metro Rail Project with corridor for a length of 8.449 km with 5 elevated stations. On operationalization of this corridor, Noid

India reaffirms commitment to climate multilateralism

India has reaffirmed its commitment to climate multilateralism and the principles of Equity and Common But Differentiated Responsibilities and Respective Capabilities (CBDR-RC), calling for a fair, equitable and ambitious outcome at the 31st Conference of the Parties (COP31) to the United Nations Framewo

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter